About OsoBio
OsoBio is a company based in Albuquerque (United States) founded in 2008 was acquired by Curia in June 2014. OsoBio offers products and services including API Manufacturing, Drug Discovery Services, and Biologics Manufacturing. OsoBio operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and LakePharma, among others.
- Headquarter Albuquerque, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curia Global, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OsoBio
OsoBio offers a comprehensive portfolio of products and services, including API Manufacturing, Drug Discovery Services, and Biologics Manufacturing.
Produces active pharmaceutical ingredients for drug development
Supports early-stage drug discovery and screening processes
Handles production of biologics for clinical and commercial use
Funding Insights of OsoBio
Detailed funding history for OsoBio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in OsoBio
OsoBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug research, development, testing, and consulting services are provided.
|
Locked | Locked | Locked |
Investor details for OsoBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OsoBio
Investment portfolio details for OsoBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OsoBio
Detailed financials for OsoBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Osobio Comparisons
Peer comparison for OsoBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OsoBio
OsoBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and LakePharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| Locked | Locked | Locked |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
|
| Locked | Locked | Locked |
Provides enabling tools and services in the life sciences research and bio-production industries
|
Detailed competitors of OsoBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Osobio
Complete news archive for OsoBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OsoBio
OsoBio was founded in 2008.
OsoBio is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
OsoBio was founded in 2008 and is based in Albuquerque, United States. Operations focus on the pharmaceutical and biologic sectors as a contract manufacturing organization. Sterile injectable liquids, suspensions, and lyophilized products are produced for various therapeutic categories. Over 250 distinct commercial presentations have been manufactured. Services include vial filling, lyophilization, terminal sterilization, packaging, and handling of potent compounds, cytotoxics, monoclonal antibodies, suspensions, proteins, and inactivated vaccines.
OsoBio's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
OsoBio offers API Manufacturing, Drug Discovery Services, and Biologics Manufacturing.
OsoBio has 1 investor. Key investors include Curia.